Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Change in Inventory (2023 - 2025)

Bioregenx (BRGX) has 3 years of Change in Inventory data on record, last reported at -$24852.0 in Q3 2025.

  • For Q3 2025, Change in Inventory fell 267.9% year-over-year to -$24852.0; the TTM value through Sep 2025 reached -$49348.0, down 144.81%, while the annual FY2024 figure was -$106435.0, 393.75% down from the prior year.
  • Change in Inventory reached -$24852.0 in Q3 2025 per BRGX's latest filing, down from -$6208.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $140156.0 in Q1 2023 and bottomed at -$79245.0 in Q3 2023.
  • Average Change in Inventory over 3 years is -$6538.0, with a median of -$6208.0 recorded in 2025.
  • The widest YoY moves for Change in Inventory: up 801.0% in 2025, down 267.9% in 2025.
  • A 3-year view of Change in Inventory shows it stood at $38645.0 in 2023, then tumbled by 223.26% to -$47632.0 in 2024, then skyrocketed by 47.82% to -$24852.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Inventory were -$24852.0 in Q3 2025, -$6208.0 in Q2 2025, and $29344.0 in Q1 2025.